Advertisement

Topics

FDA probes blood cancer immunotherapy safety

07:51 EDT 1 Sep 2017 | pharmaphorum

The FDA is to probe safety concerns about cancer immunotherapies combinations in the light of signals from two trials involving Merck & Co’s Keytruda. The FDA has notified healthcare providers of increased death risks associated with Keyt...

Original Article: FDA probes blood cancer immunotherapy safety

NEXT ARTICLE

More From BioPortfolio on "FDA probes blood cancer immunotherapy safety"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...